Pilot Study Comparison of Combigan BID vs Simbrinza TID in Subjects Currently Treated With Latanoprost For Open-Angle Glaucoma or Ocular Hypertension
Phase of Trial: Phase IV
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Brimonidine/timolol (Primary) ; Brimonidine/brinzolamide
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- 20 Feb 2017 Planned number of patients changed from 40 to 43.
- 20 Feb 2017 Planned End Date changed from 1 Oct 2015 to 1 Sep 2017.
- 20 Feb 2017 Planned primary completion date changed from 1 Jul 2015 to 1 Sep 2017.